Compare J.B.Chemicals with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AUROBINDO PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AUROBINDO PHARMA J.B.CHEMICALS/
AUROBINDO PHARMA
 
P/E (TTM) x 15.3 10.8 141.9% View Chart
P/BV x 2.1 2.3 90.2% View Chart
Dividend Yield % 0.6 0.5 104.1%  

Financials

 J.B.CHEMICALS   AUROBINDO PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
AUROBINDO PHARMA
Mar-18
J.B.CHEMICALS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs363809 44.9%   
Low Rs255504 50.6%   
Sales per share (Unadj.) Rs169.1281.1 60.2%  
Earnings per share (Unadj.) Rs16.641.4 40.1%  
Cash flow per share (Unadj.) Rs23.450.9 46.0%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.60.4 169.9%  
Book value per share (Unadj.) Rs172.5199.4 86.5%  
Shares outstanding (eoy) m83.57585.88 14.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.82.3 78.2%   
Avg P/E ratio x18.615.9 117.3%  
P/CF ratio (eoy) x13.212.9 102.3%  
Price / Book Value ratio x1.83.3 54.4%  
Dividend payout %12.06.0 199.3%   
Avg Mkt Cap Rs m25,827384,630 6.7%   
No. of employees `0003.817.3 21.8%   
Total wages/salary Rs m2,51121,308 11.8%   
Avg. sales/employee Rs Th3,747.49,500.7 39.4%   
Avg. wages/employee Rs Th665.71,229.4 54.1%   
Avg. net profit/employee Rs Th367.81,397.9 26.3%   
INCOME DATA
Net Sales Rs m14,135164,666 8.6%  
Other income Rs m3661,020 35.9%   
Total revenues Rs m14,501165,686 8.8%   
Gross profit Rs m2,17837,718 5.8%  
Depreciation Rs m5705,580 10.2%   
Interest Rs m35777 4.5%   
Profit before tax Rs m1,94032,380 6.0%   
Minority Interest Rs m031 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5528,183 6.7%   
Profit after tax Rs m1,38724,229 5.7%  
Gross profit margin %15.422.9 67.3%  
Effective tax rate %28.525.3 112.7%   
Net profit margin %9.814.7 66.7%  
BALANCE SHEET DATA
Current assets Rs m10,470121,878 8.6%   
Current liabilities Rs m2,74986,806 3.2%   
Net working cap to sales %54.621.3 256.5%  
Current ratio x3.81.4 271.3%  
Inventory Days Days55130 42.5%  
Debtors Days Days7868 113.6%  
Net fixed assets Rs m5,81181,037 7.2%   
Share capital Rs m167586 28.5%   
"Free" reserves Rs m14,248116,218 12.3%   
Net worth Rs m14,416116,804 12.3%   
Long term debt Rs m04,512 0.0%   
Total assets Rs m17,649211,052 8.4%  
Interest coverage x56.642.7 132.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 102.7%   
Return on assets %8.111.8 68.0%  
Return on equity %9.620.7 46.4%  
Return on capital %13.727.4 50.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16480,727 7.6%   
Fx outflow Rs m1,33434,700 3.8%   
Net fx Rs m4,82946,027 10.5%   
CASH FLOW
From Operations Rs m1,23119,548 6.3%  
From Investments Rs m-208-19,570 1.1%  
From Financial Activity Rs m-5958,642 -6.9%  
Net Cashflow Rs m4278,922 4.8%  

Share Holding

Indian Promoters % 55.4 54.1 102.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 8.0 42.6%  
FIIs % 3.9 27.7 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.2 362.7%  
Shareholders   30,437 69,601 43.7%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Gains; Tata Motors & ONGC Climb 5%(12:30 pm)

Share markets in India have extended early morning gains and are presently trading higher. Investors are cautious ahead of the release of Consumer Price Index-based inflation.

Related Views on News

AUROBINDO PHARMA Surges by 6%; BSE HEALTHCARE Index Up 1.3% (Market Updates)

Oct 14, 2019 | Updated on Oct 14, 2019

AUROBINDO PHARMA share price has surged by 6% and its current market price is Rs 464. The BSE HEALTHCARE is up by 1.3%. The top gainers in the BSE HEALTHCARE Index is AUROBINDO PHARMA (up 5.7%). The top losers are FDC LTD. and DIVIS LABORATORIES (down 0.3%).

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Oct 14, 2019 01:39 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - ABBOTT INDIA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS